Verteporfin photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia: a 12-month retrospective review.

Costagliola, C; Campa, C; Incorvaia, C; Parmeggiani, F; Menzione, M; Della Corte, M; Rinaldi, M; Romano, M; Semeraro, F

Costagliola, C; Campa, C; Incorvaia, C; Parmeggiani, F; Menzione, M; Della Corte, M; Rinaldi, M; Romano, M; Semeraro, F.

Affiliation

Costagliola C; Dipartimento di Scienze per la Salute, Università degli Studi del Molise, Campobasso - Italy. ciro.costagliola@unimol.it

Eur J Ophthalmol ; 18(6): 955-9, 2008.

Article in En | MEDLINE | ID: mdl-18988168

Subject(s)

Choroidal Neovascularization/drug therapy; Myopia, Degenerative/complications; Photochemotherapy; Photosensitizing Agents/therapeutic use; Porphyrins/therapeutic use; Adult; Aged; Aged, 80 and over; Choroidal Neovascularization/etiology; Choroidal Neovascularization/physiopathology; Female; Fluorescein Angiography; Fovea Centralis; Humans; Male; Middle Aged; Myopia, Degenerative/physiopathology; Retrospective Studies; Treatment Outcome; Verteporfin; Visual Acuity/physiology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Photochemotherapy / Porphyrins / Photosensitizing Agents / Choroidal Neovascularization / Myopia, Degenerative Type of study: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Eur J Ophthalmol Journal subject: OFTALMOLOGIA Year: 2008 Type: Article

Search on Google

XML

PubMed Links